Global Pulmonary Drug Delivery Devices Supply, Demand and Key Producers, 2023-2029
Page: 126
Published Date: 21 Apr 2023
Category: Medical Devices & Consumables
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
The global Pulmonary Drug Delivery Devices market size is expected to reach $ 3844.5 million by 2029, rising at a market growth of 4.0% CAGR during the forecast period (2023-2029).
This report studies the global Pulmonary Drug Delivery Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pulmonary Drug Delivery Devices, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pulmonary Drug Delivery Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pulmonary Drug Delivery Devices total production and demand, 2018-2029, (K Units)
Global Pulmonary Drug Delivery Devices total production value, 2018-2029, (USD Million)
Global Pulmonary Drug Delivery Devices production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pulmonary Drug Delivery Devices consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Pulmonary Drug Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Pulmonary Drug Delivery Devices production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Pulmonary Drug Delivery Devices production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Pulmonary Drug Delivery Devices production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Pulmonary Drug Delivery Devices market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim GmbH, Novartis AG, GlaxoSmithKline, AstraZeneca, Teva Pharmaceutical Industries, Merck, MannKind, Bristol-Myers Squibb and Mylan N.V, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Pulmonary Drug Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (USD/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Pulmonary Drug Delivery Devices Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pulmonary Drug Delivery Devices Market, Segmentation by Type
Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Global Pulmonary Drug Delivery Devices Market, Segmentation by Application
Asthma
COPD
Cystic Fibrosis
Other
Companies Profiled:
Boehringer Ingelheim GmbH
Novartis AG
GlaxoSmithKline
AstraZeneca
Teva Pharmaceutical Industries
Merck
MannKind
Bristol-Myers Squibb
Mylan N.V
Omron Corp
F. Hoffmann-La Roche
3M Healthcare
Sunovion Pharmaceuticals
Koninklijke Philips N.V
Gerresheimer AG
Bespak
AptarGroup
SHL Group
Nypro Healthcare
Hovione
Chiesi Farmaceutici S.P.A
Key Questions Answered
1. How big is the global Pulmonary Drug Delivery Devices market?
2. What is the demand of the global Pulmonary Drug Delivery Devices market?
3. What is the year over year growth of the global Pulmonary Drug Delivery Devices market?
4. What is the production and production value of the global Pulmonary Drug Delivery Devices market?
5. Who are the key producers in the global Pulmonary Drug Delivery Devices market?
6. What are the growth factors driving the market demand?
Table of Contents
1 Supply Summary
1.1 Pulmonary Drug Delivery Devices Introduction
1.2 World Pulmonary Drug Delivery Devices Supply & Forecast
1.2.1 World Pulmonary Drug Delivery Devices Production Value (2018 & 2022 & 2029)
1.2.2 World Pulmonary Drug Delivery Devices Production (2018-2029)
1.2.3 World Pulmonary Drug Delivery Devices Pricing Trends (2018-2029)
1.3 World Pulmonary Drug Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Pulmonary Drug Delivery Devices Production Value by Region (2018-2029)
1.3.2 World Pulmonary Drug Delivery Devices Production by Region (2018-2029)
1.3.3 World Pulmonary Drug Delivery Devices Average Price by Region (2018-2029)
1.3.4 North America Pulmonary Drug Delivery Devices Production (2018-2029)
1.3.5 Europe Pulmonary Drug Delivery Devices Production (2018-2029)
1.3.6 China Pulmonary Drug Delivery Devices Production (2018-2029)
1.3.7 Japan Pulmonary Drug Delivery Devices Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Pulmonary Drug Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Pulmonary Drug Delivery Devices Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2.1 World Pulmonary Drug Delivery Devices Demand (2018-2029)
2.2 World Pulmonary Drug Delivery Devices Consumption by Region
2.2.1 World Pulmonary Drug Delivery Devices Consumption by Region (2018-2023)
2.2.2 World Pulmonary Drug Delivery Devices Consumption Forecast by Region (2024-2029)
2.3 United States Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.4 China Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.5 Europe Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.6 Japan Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.7 South Korea Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.8 ASEAN Pulmonary Drug Delivery Devices Consumption (2018-2029)
2.9 India Pulmonary Drug Delivery Devices Consumption (2018-2029)
3.1 World Pulmonary Drug Delivery Devices Production Value by Manufacturer (2018-2023)
3.2 World Pulmonary Drug Delivery Devices Production by Manufacturer (2018-2023)
3.3 World Pulmonary Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Pulmonary Drug Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Pulmonary Drug Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Pulmonary Drug Delivery Devices in 2022
3.5.3 Global Concentration Ratios (CR8) for Pulmonary Drug Delivery Devices in 2022
3.6 Pulmonary Drug Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Pulmonary Drug Delivery Devices Market: Region Footprint
3.6.2 Pulmonary Drug Delivery Devices Market: Company Product Type Footprint
3.6.3 Pulmonary Drug Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4.1 United States VS China: Pulmonary Drug Delivery Devices Production Value Comparison
4.1.1 United States VS China: Pulmonary Drug Delivery Devices Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Pulmonary Drug Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Pulmonary Drug Delivery Devices Production Comparison
4.2.1 United States VS China: Pulmonary Drug Delivery Devices Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Pulmonary Drug Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Pulmonary Drug Delivery Devices Consumption Comparison
4.3.1 United States VS China: Pulmonary Drug Delivery Devices Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Pulmonary Drug Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Pulmonary Drug Delivery Devices Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Pulmonary Drug Delivery Devices Production Value (2018-2023)
4.4.3 United States Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023)
4.5 China Based Pulmonary Drug Delivery Devices Manufacturers and Market Share
4.5.1 China Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Pulmonary Drug Delivery Devices Production Value (2018-2023)
4.5.3 China Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023)
4.6 Rest of World Based Pulmonary Drug Delivery Devices Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023)
5.1 World Pulmonary Drug Delivery Devices Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Dry Powder Inhaler
5.2.2 Metered Dose Inhaler
5.2.3 Nebulizer
5.3 Market Segment by Type
5.3.1 World Pulmonary Drug Delivery Devices Production by Type (2018-2029)
5.3.2 World Pulmonary Drug Delivery Devices Production Value by Type (2018-2029)
5.3.3 World Pulmonary Drug Delivery Devices Average Price by Type (2018-2029)
6.1 World Pulmonary Drug Delivery Devices Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Asthma
6.2.2 COPD
6.2.3 Cystic Fibrosis
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Pulmonary Drug Delivery Devices Production by Application (2018-2029)
6.3.2 World Pulmonary Drug Delivery Devices Production Value by Application (2018-2029)
6.3.3 World Pulmonary Drug Delivery Devices Average Price by Application (2018-2029)
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Details
7.1.2 Boehringer Ingelheim GmbH Major Business
7.1.3 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
7.1.4 Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Boehringer Ingelheim GmbH Recent Developments/Updates
7.1.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
7.2 Novartis AG
7.2.1 Novartis AG Details
7.2.2 Novartis AG Major Business
7.2.3 Novartis AG Pulmonary Drug Delivery Devices Product and Services
7.2.4 Novartis AG Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Novartis AG Recent Developments/Updates
7.2.6 Novartis AG Competitive Strengths & Weaknesses
7.3 GlaxoSmithKline
7.3.1 GlaxoSmithKline Details
7.3.2 GlaxoSmithKline Major Business
7.3.3 GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
7.3.4 GlaxoSmithKline Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 GlaxoSmithKline Recent Developments/Updates
7.3.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.4 AstraZeneca
7.4.1 AstraZeneca Details
7.4.2 AstraZeneca Major Business
7.4.3 AstraZeneca Pulmonary Drug Delivery Devices Product and Services
7.4.4 AstraZeneca Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 AstraZeneca Recent Developments/Updates
7.4.6 AstraZeneca Competitive Strengths & Weaknesses
7.5 Teva Pharmaceutical Industries
7.5.1 Teva Pharmaceutical Industries Details
7.5.2 Teva Pharmaceutical Industries Major Business
7.5.3 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
7.5.4 Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Pharmaceutical Industries Recent Developments/Updates
7.5.6 Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
7.6 Merck
7.6.1 Merck Details
7.6.2 Merck Major Business
7.6.3 Merck Pulmonary Drug Delivery Devices Product and Services
7.6.4 Merck Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Merck Recent Developments/Updates
7.6.6 Merck Competitive Strengths & Weaknesses
7.7 MannKind
7.7.1 MannKind Details
7.7.2 MannKind Major Business
7.7.3 MannKind Pulmonary Drug Delivery Devices Product and Services
7.7.4 MannKind Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 MannKind Recent Developments/Updates
7.7.6 MannKind Competitive Strengths & Weaknesses
7.8 Bristol-Myers Squibb
7.8.1 Bristol-Myers Squibb Details
7.8.2 Bristol-Myers Squibb Major Business
7.8.3 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
7.8.4 Bristol-Myers Squibb Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Bristol-Myers Squibb Recent Developments/Updates
7.8.6 Bristol-Myers Squibb Competitive Strengths & Weaknesses
7.9 Mylan N.V
7.9.1 Mylan N.V Details
7.9.2 Mylan N.V Major Business
7.9.3 Mylan N.V Pulmonary Drug Delivery Devices Product and Services
7.9.4 Mylan N.V Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Mylan N.V Recent Developments/Updates
7.9.6 Mylan N.V Competitive Strengths & Weaknesses
7.10 Omron Corp
7.10.1 Omron Corp Details
7.10.2 Omron Corp Major Business
7.10.3 Omron Corp Pulmonary Drug Delivery Devices Product and Services
7.10.4 Omron Corp Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Omron Corp Recent Developments/Updates
7.10.6 Omron Corp Competitive Strengths & Weaknesses
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Details
7.11.2 F. Hoffmann-La Roche Major Business
7.11.3 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
7.11.4 F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 F. Hoffmann-La Roche Recent Developments/Updates
7.11.6 F. Hoffmann-La Roche Competitive Strengths & Weaknesses
7.12 3M Healthcare
7.12.1 3M Healthcare Details
7.12.2 3M Healthcare Major Business
7.12.3 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
7.12.4 3M Healthcare Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 3M Healthcare Recent Developments/Updates
7.12.6 3M Healthcare Competitive Strengths & Weaknesses
7.13 Sunovion Pharmaceuticals
7.13.1 Sunovion Pharmaceuticals Details
7.13.2 Sunovion Pharmaceuticals Major Business
7.13.3 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
7.13.4 Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.13.5 Sunovion Pharmaceuticals Recent Developments/Updates
7.13.6 Sunovion Pharmaceuticals Competitive Strengths & Weaknesses
7.14 Koninklijke Philips N.V
7.14.1 Koninklijke Philips N.V Details
7.14.2 Koninklijke Philips N.V Major Business
7.14.3 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
7.14.4 Koninklijke Philips N.V Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.14.5 Koninklijke Philips N.V Recent Developments/Updates
7.14.6 Koninklijke Philips N.V Competitive Strengths & Weaknesses
7.15 Gerresheimer AG
7.15.1 Gerresheimer AG Details
7.15.2 Gerresheimer AG Major Business
7.15.3 Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
7.15.4 Gerresheimer AG Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.15.5 Gerresheimer AG Recent Developments/Updates
7.15.6 Gerresheimer AG Competitive Strengths & Weaknesses
7.16 Bespak
7.16.1 Bespak Details
7.16.2 Bespak Major Business
7.16.3 Bespak Pulmonary Drug Delivery Devices Product and Services
7.16.4 Bespak Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.16.5 Bespak Recent Developments/Updates
7.16.6 Bespak Competitive Strengths & Weaknesses
7.17 AptarGroup
7.17.1 AptarGroup Details
7.17.2 AptarGroup Major Business
7.17.3 AptarGroup Pulmonary Drug Delivery Devices Product and Services
7.17.4 AptarGroup Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.17.5 AptarGroup Recent Developments/Updates
7.17.6 AptarGroup Competitive Strengths & Weaknesses
7.18 SHL Group
7.18.1 SHL Group Details
7.18.2 SHL Group Major Business
7.18.3 SHL Group Pulmonary Drug Delivery Devices Product and Services
7.18.4 SHL Group Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.18.5 SHL Group Recent Developments/Updates
7.18.6 SHL Group Competitive Strengths & Weaknesses
7.19 Nypro Healthcare
7.19.1 Nypro Healthcare Details
7.19.2 Nypro Healthcare Major Business
7.19.3 Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
7.19.4 Nypro Healthcare Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.19.5 Nypro Healthcare Recent Developments/Updates
7.19.6 Nypro Healthcare Competitive Strengths & Weaknesses
7.20 Hovione
7.20.1 Hovione Details
7.20.2 Hovione Major Business
7.20.3 Hovione Pulmonary Drug Delivery Devices Product and Services
7.20.4 Hovione Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.20.5 Hovione Recent Developments/Updates
7.20.6 Hovione Competitive Strengths & Weaknesses
7.21 Chiesi Farmaceutici S.P.A
7.21.1 Chiesi Farmaceutici S.P.A Details
7.21.2 Chiesi Farmaceutici S.P.A Major Business
7.21.3 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
7.21.4 Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.21.5 Chiesi Farmaceutici S.P.A Recent Developments/Updates
7.21.6 Chiesi Farmaceutici S.P.A Competitive Strengths & Weaknesses
8.1 Pulmonary Drug Delivery Devices Industry Chain
8.2 Pulmonary Drug Delivery Devices Upstream Analysis
8.2.1 Pulmonary Drug Delivery Devices Core Raw Materials
8.2.2 Main Manufacturers of Pulmonary Drug Delivery Devices Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Pulmonary Drug Delivery Devices Production Mode
8.6 Pulmonary Drug Delivery Devices Procurement Model
8.7 Pulmonary Drug Delivery Devices Industry Sales Model and Sales Channels
8.7.1 Pulmonary Drug Delivery Devices Sales Model
8.7.2 Pulmonary Drug Delivery Devices Typical Customers
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. World Pulmonary Drug Delivery Devices Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Pulmonary Drug Delivery Devices Production Value by Region (2018-2023) & (USD Million)
Table 3. World Pulmonary Drug Delivery Devices Production Value by Region (2024-2029) & (USD Million)
Table 4. World Pulmonary Drug Delivery Devices Production Value Market Share by Region (2018-2023)
Table 5. World Pulmonary Drug Delivery Devices Production Value Market Share by Region (2024-2029)
Table 6. World Pulmonary Drug Delivery Devices Production by Region (2018-2023) & (K Units)
Table 7. World Pulmonary Drug Delivery Devices Production by Region (2024-2029) & (K Units)
Table 8. World Pulmonary Drug Delivery Devices Production Market Share by Region (2018-2023)
Table 9. World Pulmonary Drug Delivery Devices Production Market Share by Region (2024-2029)
Table 10. World Pulmonary Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 11. World Pulmonary Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 12. Pulmonary Drug Delivery Devices Major Market Trends
Table 13. World Pulmonary Drug Delivery Devices Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Pulmonary Drug Delivery Devices Consumption by Region (2018-2023) & (K Units)
Table 15. World Pulmonary Drug Delivery Devices Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Pulmonary Drug Delivery Devices Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Pulmonary Drug Delivery Devices Producers in 2022
Table 18. World Pulmonary Drug Delivery Devices Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Pulmonary Drug Delivery Devices Producers in 2022
Table 20. World Pulmonary Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 21. Global Pulmonary Drug Delivery Devices Company Evaluation Quadrant
Table 22. World Pulmonary Drug Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Pulmonary Drug Delivery Devices Production Site of Key Manufacturer
Table 24. Pulmonary Drug Delivery Devices Market: Company Product Type Footprint
Table 25. Pulmonary Drug Delivery Devices Market: Company Product Application Footprint
Table 26. Pulmonary Drug Delivery Devices Competitive Factors
Table 27. Pulmonary Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Pulmonary Drug Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Pulmonary Drug Delivery Devices Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Pulmonary Drug Delivery Devices Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Pulmonary Drug Delivery Devices Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Pulmonary Drug Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Pulmonary Drug Delivery Devices Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share (2018-2023)
Table 37. China Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Pulmonary Drug Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Pulmonary Drug Delivery Devices Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share (2018-2023)
Table 42. Rest of World Based Pulmonary Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share (2018-2023)
Table 47. World Pulmonary Drug Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Pulmonary Drug Delivery Devices Production by Type (2018-2023) & (K Units)
Table 49. World Pulmonary Drug Delivery Devices Production by Type (2024-2029) & (K Units)
Table 50. World Pulmonary Drug Delivery Devices Production Value by Type (2018-2023) & (USD Million)
Table 51. World Pulmonary Drug Delivery Devices Production Value by Type (2024-2029) & (USD Million)
Table 52. World Pulmonary Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 53. World Pulmonary Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 54. World Pulmonary Drug Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Pulmonary Drug Delivery Devices Production by Application (2018-2023) & (K Units)
Table 56. World Pulmonary Drug Delivery Devices Production by Application (2024-2029) & (K Units)
Table 57. World Pulmonary Drug Delivery Devices Production Value by Application (2018-2023) & (USD Million)
Table 58. World Pulmonary Drug Delivery Devices Production Value by Application (2024-2029) & (USD Million)
Table 59. World Pulmonary Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 60. World Pulmonary Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 61. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 62. Boehringer Ingelheim GmbH Major Business
Table 63. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Product and Services
Table 64. Boehringer Ingelheim GmbH Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 66. Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses
Table 67. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 68. Novartis AG Major Business
Table 69. Novartis AG Pulmonary Drug Delivery Devices Product and Services
Table 70. Novartis AG Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Novartis AG Recent Developments/Updates
Table 72. Novartis AG Competitive Strengths & Weaknesses
Table 73. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 74. GlaxoSmithKline Major Business
Table 75. GlaxoSmithKline Pulmonary Drug Delivery Devices Product and Services
Table 76. GlaxoSmithKline Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. GlaxoSmithKline Recent Developments/Updates
Table 78. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 79. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 80. AstraZeneca Major Business
Table 81. AstraZeneca Pulmonary Drug Delivery Devices Product and Services
Table 82. AstraZeneca Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. AstraZeneca Recent Developments/Updates
Table 84. AstraZeneca Competitive Strengths & Weaknesses
Table 85. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 86. Teva Pharmaceutical Industries Major Business
Table 87. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Product and Services
Table 88. Teva Pharmaceutical Industries Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Teva Pharmaceutical Industries Recent Developments/Updates
Table 90. Teva Pharmaceutical Industries Competitive Strengths & Weaknesses
Table 91. Merck Basic Information, Manufacturing Base and Competitors
Table 92. Merck Major Business
Table 93. Merck Pulmonary Drug Delivery Devices Product and Services
Table 94. Merck Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Merck Recent Developments/Updates
Table 96. Merck Competitive Strengths & Weaknesses
Table 97. MannKind Basic Information, Manufacturing Base and Competitors
Table 98. MannKind Major Business
Table 99. MannKind Pulmonary Drug Delivery Devices Product and Services
Table 100. MannKind Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. MannKind Recent Developments/Updates
Table 102. MannKind Competitive Strengths & Weaknesses
Table 103. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 104. Bristol-Myers Squibb Major Business
Table 105. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Product and Services
Table 106. Bristol-Myers Squibb Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Bristol-Myers Squibb Recent Developments/Updates
Table 108. Bristol-Myers Squibb Competitive Strengths & Weaknesses
Table 109. Mylan N.V Basic Information, Manufacturing Base and Competitors
Table 110. Mylan N.V Major Business
Table 111. Mylan N.V Pulmonary Drug Delivery Devices Product and Services
Table 112. Mylan N.V Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Mylan N.V Recent Developments/Updates
Table 114. Mylan N.V Competitive Strengths & Weaknesses
Table 115. Omron Corp Basic Information, Manufacturing Base and Competitors
Table 116. Omron Corp Major Business
Table 117. Omron Corp Pulmonary Drug Delivery Devices Product and Services
Table 118. Omron Corp Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Omron Corp Recent Developments/Updates
Table 120. Omron Corp Competitive Strengths & Weaknesses
Table 121. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 122. F. Hoffmann-La Roche Major Business
Table 123. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Product and Services
Table 124. F. Hoffmann-La Roche Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. F. Hoffmann-La Roche Recent Developments/Updates
Table 126. F. Hoffmann-La Roche Competitive Strengths & Weaknesses
Table 127. 3M Healthcare Basic Information, Manufacturing Base and Competitors
Table 128. 3M Healthcare Major Business
Table 129. 3M Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 130. 3M Healthcare Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. 3M Healthcare Recent Developments/Updates
Table 132. 3M Healthcare Competitive Strengths & Weaknesses
Table 133. Sunovion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 134. Sunovion Pharmaceuticals Major Business
Table 135. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Product and Services
Table 136. Sunovion Pharmaceuticals Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Sunovion Pharmaceuticals Recent Developments/Updates
Table 138. Sunovion Pharmaceuticals Competitive Strengths & Weaknesses
Table 139. Koninklijke Philips N.V Basic Information, Manufacturing Base and Competitors
Table 140. Koninklijke Philips N.V Major Business
Table 141. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Product and Services
Table 142. Koninklijke Philips N.V Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Koninklijke Philips N.V Recent Developments/Updates
Table 144. Koninklijke Philips N.V Competitive Strengths & Weaknesses
Table 145. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 146. Gerresheimer AG Major Business
Table 147. Gerresheimer AG Pulmonary Drug Delivery Devices Product and Services
Table 148. Gerresheimer AG Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 149. Gerresheimer AG Recent Developments/Updates
Table 150. Gerresheimer AG Competitive Strengths & Weaknesses
Table 151. Bespak Basic Information, Manufacturing Base and Competitors
Table 152. Bespak Major Business
Table 153. Bespak Pulmonary Drug Delivery Devices Product and Services
Table 154. Bespak Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 155. Bespak Recent Developments/Updates
Table 156. Bespak Competitive Strengths & Weaknesses
Table 157. AptarGroup Basic Information, Manufacturing Base and Competitors
Table 158. AptarGroup Major Business
Table 159. AptarGroup Pulmonary Drug Delivery Devices Product and Services
Table 160. AptarGroup Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 161. AptarGroup Recent Developments/Updates
Table 162. AptarGroup Competitive Strengths & Weaknesses
Table 163. SHL Group Basic Information, Manufacturing Base and Competitors
Table 164. SHL Group Major Business
Table 165. SHL Group Pulmonary Drug Delivery Devices Product and Services
Table 166. SHL Group Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 167. SHL Group Recent Developments/Updates
Table 168. SHL Group Competitive Strengths & Weaknesses
Table 169. Nypro Healthcare Basic Information, Manufacturing Base and Competitors
Table 170. Nypro Healthcare Major Business
Table 171. Nypro Healthcare Pulmonary Drug Delivery Devices Product and Services
Table 172. Nypro Healthcare Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 173. Nypro Healthcare Recent Developments/Updates
Table 174. Nypro Healthcare Competitive Strengths & Weaknesses
Table 175. Hovione Basic Information, Manufacturing Base and Competitors
Table 176. Hovione Major Business
Table 177. Hovione Pulmonary Drug Delivery Devices Product and Services
Table 178. Hovione Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 179. Hovione Recent Developments/Updates
Table 180. Chiesi Farmaceutici S.P.A Basic Information, Manufacturing Base and Competitors
Table 181. Chiesi Farmaceutici S.P.A Major Business
Table 182. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Product and Services
Table 183. Chiesi Farmaceutici S.P.A Pulmonary Drug Delivery Devices Production (K Units), Price (USD/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 184. Global Key Players of Pulmonary Drug Delivery Devices Upstream (Raw Materials)
Table 185. Pulmonary Drug Delivery Devices Typical Customers
Table 186. Pulmonary Drug Delivery Devices Typical Distributors
List of Figure
Figure 1. Pulmonary Drug Delivery Devices Picture
Figure 2. World Pulmonary Drug Delivery Devices Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Pulmonary Drug Delivery Devices Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Pulmonary Drug Delivery Devices Production (2018-2029) & (K Units)
Figure 5. World Pulmonary Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
Figure 6. World Pulmonary Drug Delivery Devices Production Value Market Share by Region (2018-2029)
Figure 7. World Pulmonary Drug Delivery Devices Production Market Share by Region (2018-2029)
Figure 8. North America Pulmonary Drug Delivery Devices Production (2018-2029) & (K Units)
Figure 9. Europe Pulmonary Drug Delivery Devices Production (2018-2029) & (K Units)
Figure 10. China Pulmonary Drug Delivery Devices Production (2018-2029) & (K Units)
Figure 11. Japan Pulmonary Drug Delivery Devices Production (2018-2029) & (K Units)
Figure 12. Pulmonary Drug Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 15. World Pulmonary Drug Delivery Devices Consumption Market Share by Region (2018-2029)
Figure 16. United States Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 17. China Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 18. Europe Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 19. Japan Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 20. South Korea Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 22. India Pulmonary Drug Delivery Devices Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Pulmonary Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Pulmonary Drug Delivery Devices Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Pulmonary Drug Delivery Devices Markets in 2022
Figure 26. United States VS China: Pulmonary Drug Delivery Devices Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Pulmonary Drug Delivery Devices Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Pulmonary Drug Delivery Devices Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share 2022
Figure 30. China Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Pulmonary Drug Delivery Devices Production Market Share 2022
Figure 32. World Pulmonary Drug Delivery Devices Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Pulmonary Drug Delivery Devices Production Value Market Share by Type in 2022
Figure 34. Dry Powder Inhaler
Figure 35. Metered Dose Inhaler
Figure 36. Nebulizer
Figure 37. World Pulmonary Drug Delivery Devices Production Market Share by Type (2018-2029)
Figure 38. World Pulmonary Drug Delivery Devices Production Value Market Share by Type (2018-2029)
Figure 39. World Pulmonary Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 40. World Pulmonary Drug Delivery Devices Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 41. World Pulmonary Drug Delivery Devices Production Value Market Share by Application in 2022
Figure 42. Asthma
Figure 43. COPD
Figure 44. Cystic Fibrosis
Figure 45. Other
Figure 46. World Pulmonary Drug Delivery Devices Production Market Share by Application (2018-2029)
Figure 47. World Pulmonary Drug Delivery Devices Production Value Market Share by Application (2018-2029)
Figure 48. World Pulmonary Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 49. Pulmonary Drug Delivery Devices Industry Chain
Figure 50. Pulmonary Drug Delivery Devices Procurement Model
Figure 51. Pulmonary Drug Delivery Devices Sales Model
Figure 52. Pulmonary Drug Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 53. Methodology
Figure 54. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Boehringer Ingelheim GmbH Novartis AG GlaxoSmithKline AstraZeneca Teva Pharmaceutical Industries Merck MannKind Bristol-Myers Squibb Mylan N.V Omron Corp F. Hoffmann-La Roche 3M Healthcare Sunovion Pharmaceuticals Koninklijke Philips N.V Gerresheimer AG Bespak AptarGroup SHL Group Nypro Healthcare Hovione Chiesi Farmaceutici S.P.A
Related Reports
19 Feb 2021
Medical Devices & Consumables
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
